PDCD1LG2 and endometrial cancer: To the best of our knowledge, this is the first study to evaluate PD-L1 and PD-L2 expression on myeloid and plasmacytoid dendritic cells, as well as on monocytes, in patients with endometrial cancer using flow cytometry.